Goldman Sachs Initiates Coverage On Versigent with Buy Rating, Announces Price Target of $48

Benzinga · 4d ago
Goldman Sachs analyst Mark Delaney initiates coverage on Versigent (NYSE:VGNT) with a Buy rating and announces Price Target of $48.